Advertisement

Journal of Nuclear Cardiology

, Volume 11, Issue 4, pp 450–457 | Cite as

Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography

  • D. Vijay Anand
  • Eric Lim
  • Usha Raval
  • David Lipkin
  • Avijit LahiriEmail author
Article

Abstract

Background

Electron beam tomography coronary calcium imaging is an evolving technique for the early detection of coronary atherosclerosis, and recent studies have established its prognostic value in asymptomatic individuals. The relationship of coronary artery calcium scores (CAC) to obstructive coronary artery disease (CAD) has been poorly studied but is clinically relevant because it determines which individuals are likely to benefit from revascularization procedures. Hence, we prospectively evaluated the prevalence of myocardial ischemia in asymptomatic patients with cardiovascular risk factors and subclinical atherosclerosis.

Methods and Results

We studied 864 asymptomatic patients with no previous CAD but with cardiovascular risk factors, referred for electron beam tomography coronary calcium imaging to our institution over an 18-month period. From this group, 220 consecutive patients (85% men; mean age, 61 ± 9 years; age range, 31-84 years) with moderate to severe atherosclerotic disease (coronary calcium score ≥100 Agatston units) were prospectively evaluated by technetium 99m sestamibi single photon emission computed tomography (SPECT). Patients were followed up (mean follow-up, 14 months) and data regarding their subsequent clinical management recorded. Of the 220 patients, 119 had moderate atherosclerosis (CAC score of 100-400 Agatston units) and 101 had severe atherosclerosis (CAC score ≥400 Agatston units). Abnormal SPECT findings were seen in 18% of patients with moderate atherosclerosis (n =21) and 45% of patients with severe atherosclerosis (n = 45). Increasing severity of atherosclerosis was related to increasing ischemic burden (summed difference score = 1 ± 0.2 for CAC score of 100-400 Agatston units and 3.2 ± 0.5 for CAC score ≥400 Agatston units). In a multivariate linear regression model incorporating risk factors, CAC was the only predictor of silent ischemia.

Conclusion

In comparison to previously published data, we detected a higher prevalence of silent ischemia even in patients with moderate coronary atherosclerosis (18%). This may reflect the differing risk factor profile of our patient population. When coronary calcium screening is used to preselect asymptomatic patients with cardiovascular risk factors for myocardial perfusion imaging, the optimum coronary calcium score threshold will depend on the population prevalence of risk factors and asymptomatic obstructive CAD.

Key Words

Coronary artery disease atherosclerosis electron beam tomography coronary artery calcium score silent myocardial ischemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657–71.PubMedGoogle Scholar
  2. 2.
    Iskandrian AS, Chae SC, Heo J, et al. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665–70.PubMedGoogle Scholar
  3. 3.
    Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation 1995;92:2157–62.PubMedGoogle Scholar
  4. 4.
    Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron beam computed tomography. Circulation 2000;101:850–5.PubMedGoogle Scholar
  5. 5.
    Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events. A 37-month follow-up of 5635 initially asymptomatic low-to intermediate-risk adults. Circulation 2003;107:2571–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Shaw LJ, Raggi P, Schisterman E, Berman D, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003;228:826–33.PubMedCrossRefGoogle Scholar
  7. 7.
    Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC.Coronary artery calcium score combined with Framingham risk score for risk prediction in asymptomatic individuals. JAMA 2004;291:210–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Haberl R, Becker A, Leber A, et al. Correlation of coronary artery calcification with angiographically documented stenosis in patients with suspected coronary artery disease: results of 1764 patients. J Am Coll Cardiol 2001;37:451–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Schmermund A, Baumgart D, Gorge G, et al. Coronary artery calcium in acute coronary syndromes: a comparative study of electron-beam computed tomography, coronary angiography and intracoronary ultrasound in survivors of acute myocardial infarction and unstable angina. Circulation 1997;96:1461–9.PubMedGoogle Scholar
  10. 10.
    He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation 2000;101:244–51.PubMedGoogle Scholar
  11. 11.
    Miranda R, Schisterman E, Gallagher A, et al. The extent of coronary calcium by electron beam computed tomography discriminates the likelihood of abnormal myocardial perfusion SPECT [abstract]. Circulation 2000;102:II-543.Google Scholar
  12. 12.
    Moser KW, O’Keefe JH, Bateman TM, McGhie IA. Coronary calcium screening as a guide to risk factor modification and stress myocardial perfusion imaging. J Nucl Cardiol 2003;10:590–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Lu B, Mao SS, Zhuang N, et al. Coronary artery motion during the cardiac cycle and optimal ECG triggering for coronary artery imaging. Invest Radiol 2001;36:250–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Callister TQ, Cooil B, Raya SP, et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron beam CT volumetric method. Radiology 1998;208:807–14.PubMedGoogle Scholar
  16. 16.
    Rumberger J, Brundage B, Rader D, Kondos G. Electron beam computed tomography coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999;74:243–52.PubMedCrossRefGoogle Scholar
  17. 17.
    Soman P, Taillefer R, DePuey EG, Udelson JE, Lahiri A. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. J Am Coll Cardiol 2001;37:458–62.PubMedCrossRefGoogle Scholar
  18. 18.
    Khattar RS, Senior R, Lahiri A. Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease. Heart 1998;79:274–80.PubMedGoogle Scholar
  19. 19.
    Brown KA, Heller GV, Landin RS, et al. Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and post discharge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060–6.PubMedGoogle Scholar
  20. 20.
    Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7–22.CrossRefGoogle Scholar
  21. 21.
    Shepherd J, Cobbe SM, Ford I, et al. West of Scotland coronary prevention study group: prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS study. JAMA 1998;279:1615–22.PubMedCrossRefGoogle Scholar
  23. 23.
    Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized control trial. Lancet 2003;361:1149–58.PubMedCrossRefGoogle Scholar
  24. 24.
    Taylor AJ, Feuerstein I, Wong H, et al. Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J 2001;141:463–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Greenland P, Smith JS Jr, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001;104:1863–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? Proceedings of the 34th Bethesda Conference. Bethesda, Maryland, USA. October 7, 2002. J Am Coll Cardiol 2003;41:1856–917.Google Scholar
  27. 27.
    Arad Y, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors and atherosclerotic cardiovascular disease events: the St. Francis Heart study. Late Breaking Clinical Trials III, 52nd Annual Scientific Sessions of the American College of Cardiology, March 30-April 2, 2003, Chicago, IL.Google Scholar
  28. 28.
    O’Rourke RA, Brundage BH, Froelicher VF, et al. The American College of Cardiology/American Heart Association expert consensus document on electron beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000;36:326–40.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2004

Authors and Affiliations

  • D. Vijay Anand
    • 1
    • 2
  • Eric Lim
    • 1
  • Usha Raval
    • 1
  • David Lipkin
    • 1
    • 2
  • Avijit Lahiri
    • 1
    • 3
    Email author
  1. 1.Cardiac Imaging and Research CentreThe Wellington Hospital, LondonHarrowUnited Kingdom
  2. 2.Department of CardiologyHarrowUnited Kingdom
  3. 3.Royal Free Hospital, London, and Department of CardiologyNorthwick Park HospitalHarrowUnited Kingdom

Personalised recommendations